No Detail Found!

Expression of Mir-100 as a Novel Ancillary Non-invasive Biomarker for Early Detection of Bladder Carcinoma.

Author(s)
Aneela Qureshi Al-Tibri Medical College, Isra University, Karachi Campus, Karachi, Pakistan
Amin Fahim Al-Tibri Medical College, Isra University, Karachi Campus, Karachi, Pakistan
Navaid Kazi Isra University Hyderabad, Pakistan
Salman Ahmed Farsi Kazi Isra University Hyderabad, Pakistan
Farkhunda Nadeem Isra University Hyderabad, Pakistan
Abstract
Objective: To determine the expression of microribonucleic acid-100 in bladder cancer patients and to evaluate its association with clinicopathological parameters. Methods: This cross-sectional case-control study was conducted at Jinnah Postgraduate Medical Centre Karachi and Civil Hospital Karachi from January to December 2014. Serum samples from patients having bladder carcinoma were collected, and divided into three equal groups. All the study participants were briefed about the study objectives, its outcomes, sample collection technique and their written consent was obtained. Serum samples of bladder carcinoma and healthy control subjects were divided into four equal groups. Group I included patients with papillary urothelial carcinoma of low malignant potential, group II had patients with papillary urothelial carcinoma low grade, and group III had patients with papillary urothelial carcinoma high grade. Group IV comprised healthy controls. From the serum samples, total ribonucleic acid were extracted, followed by micro ribonucleic acid extraction. The complementary deoxyribonucleic acid was synthesised and samples were further processed for real time polymerase chain reaction using the specifically designed primers of micro ribonucleic acid-100.Statistical analysis was done by SPSS 21. Results: There were 240 subjects with 60(25%) in each of the four groups. Micro ribonucleic acid-100expression was decreased in all the three patient groups compared to the control group. A significant correlation was found between the expression of micro ribonucleic acid-100 with microscopic haematuria, cytology, cystoscopy and staging (p0.05 each). Conclusion: Micro ribonucleic acid-100was down-regulated in urothelial cancer patients with significant correlation with microscopic haematuria, cytology, cystoscopy and staging.
Publication Details
Page(s) 759-763
DOI DOI not available
Published Journal: Journal of Pakistan Medical Association, Volume: 68, Issue: 5, Year: 2018

Request the full text from PASTIC

References
JemalA,XuJ,WardE,Cancer J CA Cancer J Clin,,2010,,,60,277,300
CattoJWF,,2008,Old and new urinary markers: which one is the PSA for bladder cancer,Eur Urol,7,422,5
RaabSS,LenelJ,CohenMB,,,Cytology diagnosis by key features as identified by logistic regression analysis,Cancer1994;,74,1621,6
SongT,XiaW,ShaoN,ZhangX,WangC,WuY,,2010,,Differential miRNA Expression Profiles in Bladder Urothelial Carcinomas. Asian Pacific J Cancer Prev,11,905,11
Raitanen MP, Aine R, Rintala E, Kallio J, Rajala P, Juusela H, et al. Differences between local and review urinary cytology in diagnosis of bladder cancer. An inter-observer multi-center analysis. EurUrol.2002; 41: 284-9.
CarloMC,,2009,Causes and consequences of microRNA dysregulation in cancer,Nature Rev Genetics,10,704,14
IntUrol Nephrol,,2010,,,42,95,102
TilborgAG,BangmaCH,ZwarthoffEC,ErasmusMC,,2009,Bladder cancer biomarkers and their role in surveillance and screening,Int J of Urol,16,23,30
DiederichsS,HaberDA,,2006,Sequence Variations of MicroRNAs in Human Cancer: Alterations in Predicted Secondary Structure Do Not Affect Processing,Cancer Res,66,6097,104
HankeM,HoefigK,MerzH,FellerAC,KauschI,JochamD,,2010,A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer,Urologic Oncol,28,655,61
KnowlesMA,,2008,Novel therapeutic targets in bladder cancer: mutation and expression of FGF receptors,Future Oncol,4,71,83
BuschC,Algaba F. TheWHO,,2002,WHO 1999 systems for malignancy grading of bladder cancer. Scientific foundation and translation to one another and previous systems,Virchows Arch,441,105,8
JacobsBL,LeeCT,MontieJE,,2010,Bladder cancer in 2010: How far have we come?,Cancer J Clin,60,244,72
ZabolotnevaAA,ZhavoronkovA,GarazhaAV,RoumiantsevSA,BuzdinAA,,2013,Characteristic patterns of microRNA expression in human bladder cancer,Front. Genet,3,2,5
WangS,XueS,DaiY,YangJ,ChenZ,FangX,,2012,Reduced expression of microRNA-100 confersun favorable prognosis in patients with bladder cancer,Diagn Pathol,7,1,7
MoraisDR,ReisST,VianaN,PiantinoCB,MassocoC,MouraC,,2014,The involvement of miR-100 in bladder urothelial carcinogenesis changing the expression levels of mRNA and proteins of genes related to cell proliferation, survival, apoptosis and chromosomal stability,Cancer Cell Int,14,1,8
OliveiraJC,BrassescoMS,MoralesAG,PezukJA,FedattoPF,da SilvaGN,Pacific J Cancer Prev,,2011,-100 Acts as a Tumor Suppressor in Human Bladder Carcinoma 5637 Cells,,12,3001,4
ChenXN,WangK,XuZ,LiS,LiuQ,Fu D,,2014,-133b regulates bladder cancer cell proliferation and apoptosis by targeting Bcl-w and Akt1,Cancer Cell Int,4,1,10
ZhangH,QiF,CaoY,ChenM,,2014,Down-regulated microRNA101 in bladder transitional cell carcinoma is associated with poor prognosis,Med Sci Monit,20,812,81
El-Hady MohamedLA,,2015,,OCT4 and miRNA145 Expression in Bladder Cancer. [dissertation]: Benha Univ.,,,
LiB,Wu,XuLY,DuZP,LiaoLD,Zhang HF,,2011,MiRNA profile in esophageal squamous cell carcinoma: Down-regulation of miR143 and miR-145,,717,79,88
Allegra A, Alonci A, Campo S, PennaG, Petrungaro A, GeraceD, etal. Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review).Int J Oncol. 2012; 41: 1897-912
0

Citations

0

Downloads

74

Views